AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2017
Oct 23, 2017
34117_dirs_2017-10-23_9535e268-1b06-4b42-b7e3-e1c4255dfa42.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2017-10-19
Reporting Person: Titterton Lewis H jr (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-19 | Common Stock | M | 2400 | $0.67 | Acquired | 834544 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-10-19 | Employee Stock Option | $0.67 | M | 2400 | Disposed | 2017-11-30 | Common Stock (2400) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6